
    
      A Randomized Control Trial (RCT) conducted in two tertiary level Neonatal Intensive Care Unit
      (NICU). Ethical approval is needed. Informed and written consent will be obtained prior the
      delivery from the parents of the babies before the inclusion in the study. All inborn Very
      Low Birth Weight (VLBW) infants (Birthweight less than 1500 g and Gestational Age < 32 weeks)
      with signs of RDS, spontaneously breathing and only supported by nasal-Continuous Positive
      Airway Pressure (NCPAP) in NICU, will be randomized within the first 2 hours of life to
      receive two different Non Invasive Ventilation (NIV) strategies: Nasal Synchronized
      Intermittent Positive Pressure Ventilation (N-SIPPV) or Bilevel Continuous Positive Airway
      Pressure (BiPAP).
    
  